Determination of Domperidone in Human Plasma using Liquid Chromatography Coupled to Tandem Mass Spectrometry and its Pharmacokinetic Study

Abstract

A sensitive and selective liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of domperidone (CAS number: 57808-66-9) in human plasma using paracetamol (CAS number: 103-90-2) as an internal standard (IS). Domperidone and paracetamol in plasma were extracted with ethyl acetate, separated on a C18 reversed phase column, eluted with mobile phase of acetonitrile-glacial acetic acid (0.3%) (40:60, v/v), ionized by positive ion pneumatically assisted electrospray and detected in the multi-reaction monitoring mode using precursor→product ions of m/z 426.2→175.1 for domperidone and 152→110 for the IS, respectively. The calibration curve was linear (r²≥0.99, n=5) over the concentration range of 0.2–80 ng/mL and with lower limit of detection and quantitation of 0.05 and 0.2 ng/mL. The specificity, matrix effect, recovery, sensitivity, linearity, accuracy, precision, and stabilities were validated for domperidone in human plasma. In conclusion, the validation results showed that this method was sensitive, economical and less toxic and it can successfully fulfill the requirement of clinical pharmacokinetic study of domperidone oral preparation in Chinese healthy volunteers.

Key words

domperidone - LC-MS/MS - pharmacokinetics - paracetamol

• References

• 1 Champion MC. Domperidone. Gen Pharmacol 1988; 19: 499-505
• 2 Patel BH, Suhagia BN, Patel MM et al. Determination of pantoprazole, rabeprazole, esomeprazole, domperidone and itopride in pharmaceutical products by reversed phase liquid chromatography using single mobile phase. Chromatographia 2007; 65: 743-748
• 3 Thanikachalam S, Rajappan M, Kannappan V. Stability-indicating HPLC method for simultaneous determination of pantoprazole and domperidone from their combination drug product. Chromatographia 2008; 67: 4147
• 4 Michaud V, Simard C, Turgeon J. An improved HPLC assay with fluorescence detection for the determination of domperidone and three major metabolites for application to in vitro drug metabolism studies. J Chromatogr B 2007; 852: 611-616
• 5 Walash MI, Belal F, El-Enany N et al. Second-derivative synchronous fluorometric method for the simultaneous determination of cinnarizine and domperidone in pharmaceutical preparations. J Fluoresc 2008; 18: 61-74
• 6 Yamamoto K, Hagino M, Kotaki H et al. Quantitative determination of domperidone in rat plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr B 2008; 720: 251-255
• 7 Dailly E, Drouineau MH, Gournay V et al. Population pharmacokinetics of domperidone in preterm neonates. Eur J Clin Pharmacol 2008; 64: 1197-1200
• 8 Zavitsanos AP, MacDonald C, Bassoo E et al. Determination of domperidone in human serum and human breast milk by high-performance liquid chromatography-electrospray mass spectrometry. J Chromatogr B 1999; 730: 9-24
• 9 Wu MS, Gao L, Cai XH et al. Determination of domperidone in human plasma by LC-MS and its pharmacokinetics in healthy Chinese volunteers. Acta Pharmacol Sin 2002; 23: 285-288
• 10 Bose A, Bhaumik U, Ah Ghosh et al. LC–MS simultaneous determination of itopride hydrochloride and domperidone in human plasma. Chromatographia 2009; DOI: 10.1365/s10337-009-1032-0.
• 11 Smit MJ, Sutherland FC, Hundt HK et al. Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the quantitation of domperidone in human plasma. J Chromatogr A 2002; 949: 65-70